MA
Mahendar Agarwal
About Mahendar Agarwal
Data last updated:
Mahendar Agarwal was a Director at Arihant Commo-Derivatives Private Limited (2020–2021), Director at Medionn Diagnostics Limited (2016–2019) and Director at Narayana Diagnostics Private Limited (from 2017). The companies operate in Financial Services and Healthcare.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Arihant Commo-Derivatives Private Limited U74999WB2010PTC155264 | Director | 07 Jul 2020 | 2010 | ₹6.76 Cr (FY 2025) | Active |
| Medionn Diagnostics Limited U74999WB2016PLC218034 | Director | 19 Oct 2016 | 2016 | ₹18.17 Cr (FY 2025) | Active |
| Narayana Diagnostics Private Limited U74999WB2017PTC221211 | Director | 26 May 2017 | 2017 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mahendar Agarwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mahendar Agarwal
Mahendar Agarwal was first appointed on 19 Oct 2016 as Director at Medionn Diagnostics Limited. The most recent appointment on record is 07 Jul 2020 at Arihant Commo-Derivatives Private Limited.
Mahendar Agarwal held 3 earlier board appointments: Arihant Commo-Derivatives Private Limited (Director, 07 Jul 2020 to 08 Jun 2021); Medionn Diagnostics Limited (Director, 19 Oct 2016 to 21 Jun 2019); Narayana Diagnostics Private Limited (Director, from 26 May 2017).